splenomegaly (4 cm below the costal margin) and no hepato-
Introduction atypical small or medium-sized lymphoid cells with a hyperchromatic nucleus and scanty cytoplasm; nucleoli were not The term post-thymic or mature T cell malignancies apparent ( Figure 1 ). Renal and liver biochemistry including encompasses a variety of entities which result from the clonal calcium levels were normal and Coomb's test was negative. expansion of mature T lymphocytes. Among them, two Serum lactate dehydrogenase was elevated to 515 IU/l primary T cell leukemias: T prolymphocytic leukemia (T-PLL) (normal range 200-450); beta-2 microglobulin and immunoand large granular lymphocyte (LGL) leukemia have been globulins were in the normal range. A brain CT scan showed a recognized as distinct disease entities.
1,2 An unusual T cell high-density area in the left parieto-temporal region consistent malignancy which evolves with a leukemic picture without with bleeding parenchyma. Chest, abdominal and pelvic CT skin involvement is that of Sezary cell-like leukemia. In this scans confirmed splenomegaly without evidence of hepatodisease, the cells are morphologically identical to Sezary cells but unlike Sezary syndrome the skin is not involved. [1] [2] [3] The presence of an 'atypical or aberrant' immunophenotype is not unusual in peripheral T cell malignancies, particularly in large cell, anaplastic and pleomorphic lymphomas in which lack of expression of some antigens expressed in most mature T lymphocytes, is relatively frequent. [4] [5] [6] Such atypical phenotypes are, however, rare in primary T cell leukemias. Molecular analysis of the T cell receptor (TCR) chain genes in such cases is essential, and necessary to demonstrate the T cell origin of these neoplasms.
We describe here an unusual case with a T cell lymphoid disease in which the morphological features of the circulating lymphoid cells were identical to that previously described in Sezary cell-like leukemia, as documented by light and electron microscopy studies. Unlike the cases previously reported, megaly or lymphadenopathy. Bone marrow aspirate was drygrated by heterochromatin and was highly irregular, displaying multiple narrow and deep indentations and thus indistap and trephine biopsy revealed diffuse infiltration by atypical lymphoid cells, some with irregular nuclei. Serologic studtinguishable from Sezary cells. Nucleoli were not identified or, when seen, they were small; the cytoplasm was poor in ies for Epstein-Barr virus and HTLV1 were negative. The patient was initially treated with prednisolone and one course organelles ( Figure 2 ). Molecular analysis performed on bone marrow sections by of combination chemotherapy with vincristine, doxorubicin and asparaginase resulting in the normalization of peripheral the PCR technique showed a clonal rearrangement of the TCR beta and gamma chain genes. blood counts and reduction of splenomegaly. Subsequently she received six cycles of CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) achieving a complete remission that was confirmed by molecular analysis. At Discussion present, the patient remains well and free of disease 22 months from diagnosis.
We report an unusual case of primary T cell leukemia presenting with widespread disease but no skin involvement, circulating lymphoid cells with morphological features identical to Sezary cells and an aberrant immunophenotype with Materials and methods lack of expression of most T cell antigens. The presenting features and morphology of the lymphoid cells were consistent
Immunophenotyping with the Sezary cell-like leukemia previously described.
2,3
However, the atypical phenotype was unique and different This was performed by direct and indirect immunofluorescence on peripheral blood isolated mononuclear cells with a from previously reported cases.
5,11
Although 'aberrant' immunophenotypes are not infrequent panel of monoclonal antibodies (McAb) against lymphoid and myeloid cells. Results were analyzed on a flow cytometer and in peripheral T cell lymphomas and usually relate to more aggressive behavior, 5 they are rare in primary T cell leukemias controls were set up by omission of the relevant McAb and substitution with a mouse Ig of the same isotype. The immuwhose cells express, as a rule, one or more 'pan T' antigens in the membrane, the most common phenotype being that of noalkaline phosphatase anti-phosphatase (APAAP) technique 8 was applied on bone marrow sections and cytospins to detect a CD2
The precise diagnosis of the T cell leukemias is based mainly on cell reactivity with two McAb: TIA-1 against granular structures in T lymphocytes and TIA-2 against the TCR zeta chain. syndrome. 9 The clinical course in Sezary cell-like leukemias is usually aggressive 2,11,12,13 and only one case treated with aggressive Molecular analysis chemotherapy and bone marrow transplantation 3 had a proThis was performed on bone marrow sections applying a polymerase chain reaction (PCR) and using specific primers to the beta and gamma chain genes of the T cell receptor (TCR) as previously described. 10 
Results
Immunophenotyping showed that most (Ͼ90%) peripheral blood mononuclear cells were negative with B lymphoid (CD19, CD22, CD79a, CD10, anti-human Ig, anti-kappa and anti-lambda), myeloid (CD13, CD14, CD33, anti-MPO, antiglycophorin A, CD41), stem cell-associated (CD34, HLA-Dr, TdT), natural killer (CD16, CD56, CD11b) and most T lymphoid markers (CD1 a , CD2, CD4, membrane/cytoplasmic CD3, CD5 and CD8). Most cells (Ͼ70%) were CD38 + and expressed cytoplasmic TIA-1, and 25% of them were positive with CD7 and TIA-2. A variable proportion of cells (30-60%) from the bone marrow were CD45 + , CD45RO + but CD3 negative.
Ultrastructural analysis showed that the circulating lymphoid cells were of small to medium size, with a high to medium 
